Vasculitides, particularly those affecting small vessels, are known to complicate systemic lupus erythematosus (SLE); however, isolated venulitis of the mesenteric bed has rarely been reported. Here we relate the case of a 46-year-old woman with SLE who presented with acute abdominal pain due to artery thrombosis and extended splenic ischemia requiring splenectomy. The histological examination revealed diffuse venulitis in the absence of arterial vasculitis consistent with the definition of mesenteric inflammatory veno-occlusive disease (MIVOD). Furthermore, arterial wall thickening suggestive of uncomplicated atherosclerosis was observed. Two months later, the patient suffered of severe myocardial infarction (MI) resulting from thrombosis of the anterior interventricular coronary artery with otherwise no signs of coronary disease at coronarography. Extensive work-up to establish the cause of MI was negative, with the exception of marginal, isolated and transient elevation of cardiolipin IgG (14.5 GPL,. This patient's SLE history is dramatically marked by the previously non-described association of MIVOD and two arterial thrombotic events (splenic and coronary) occurring within a two months period, and stresses the need of better understanding and prevention of vascular complications in SLE. Lupus (2018) 27, 150-153.
A 46-year-old Tunisian woman, current smoker, known since 2002 for arthralgia/arthritis, elevation of ANA, anti-U 1 -RNP, anti-Sm and anti-SSA antibodies, treated sporadically with non steroidal antiinflammatory drugs, presented in January 2012 with arthritis, malar rash, fever, angioedema and elevation of erythrocyte sedimentation rate (ESR), positive anti-dsDNA IgG (1/320, n.v. <1/80), high titre of anti-nucleosome antibodies, complement consumption, marginal isolated elevation of cardiolipin IgG (14.5 GPL, n.v. 0-5) and type III cryoglobulins. A diagnosis of SLE was made and oral glucocorticosteroids (GC) and antimalarials were introduced, resulting in rapid improvement. One month later, she developed acute, severe, left abdominal pain with abdominal tenderness, fever, novel elevation of ESR and leukocytosis (12 G/l). Anti-neutrophil cytoplasmic antibodies (ANCA) and blood test for hypercoagulability were negative, except for the persistence of isolated, marginal elevation of cardiolipin IgG (14.9 GPL). An abdominal CT-scan was consistent with splenic artery thrombosis and extended splenic ischemia. Splenectomy was performed, the dose of GC was increased and low-dose aspirin was introduced. Microscopic examination confirmed splenic artery thrombosis ( Figure 1) , with no signs of arteritis, and revealed an extended sub-occlusive lymphocytic venulitis (Figure 2) , consistent with the diagnosis of mesenteric inflammatory veno-occlusive disease (MIVOD). Despite no evidence of arteritis, intimal thickening of the splenic arteries was observed due to smooth muscle cell, collagen and leukocyte accumulation (Figures 3 and 4) . These later findings were considered consistent with early, uncomplicated atherosclerosis.
Two month later, the patient suffered of severe myocardial infarction with severely decreased left ventricular ejection fraction resulting from thrombosis of the anterior interventricular coronary artery with otherwise no signs of coronary disease at coronarography. Anticoagulation was added to anti-aggregation, and beta-blocker, conversion enzyme inhibitor and spironolactone were introduced. Antimalarials and GC were continued, with the addition of azathioprine. Rapidly, complement levels normalized, and anti-dsDNA, antinucleosome and anti-cardiolipin IgG become undetectable. During the following years, no new flare was observed, GC were slowly tapered and stopped 30 months later, while azathioprine was stopped after an additional 12 months.
Thus, this patient's SLE history is dramatically marked by the previously non-described association of MIVOD and two arterial thrombotic events (splenic and coronary) occurring within two months.
Discussion
Secondary vasculitides, with a prevalence ranging from 11% to 20%, characterize SLE. Small arteries and venules of the skin are the most common vessels involved, representing nearly 90% of cases. Medium-sized vessel involvement is less frequent. The occurrence of visceral vasculitis is uncommon in SLE but, when present, the ileum and colon are preferentially affected. Other infrequent sites are coronary arteries, pancreas, gallbladder, urinary bladder, liver and uterus. 1 However, to the best of our knowledge, no isolated splenic lymphocytic venulitis of the spleen, as described here, has been reported yet in SLE. First described in 1976, isolated mesenteric venous inflammation was associated with thrombosis leading to mesenteric ischemia. 2 In 1994, Flaherty et al. described mesenteric inflammatory veno-occlusive disease (MIVOD) (also known as enterocolic lymphocytic phlebitis, intramural mesenteric vasculitis, isolated granulomatous phlebitis, lymphocytic venulitis, idiopathic myointimal hyperplasia of mesenteric veins and necrotizing and giant cell granulomatous phlebitis) in seven patients with phlebitis affecting only the veins of the small bowel in the absence of systemic vasculitis or primary intestinal disease.
3 It is a rare but increasingly recognized cause of intestinal ischemia characterized by non-infectious venulitis predominantly infiltrated by cytotoxic T cells, with few or no polymorphonuclear cells or macrophages and variable myo-intimal hyperplasia. Histologically, the absence of arteritis is key in distinguishing MIVOD from other vasculitides. 4 MIVOD has no gender predilection and affects patients of all ages. The etiology remains unclear, 5 occasionally described in association with drugs, 6 Behc¸et syndrome, antiphospholipid syndrome or infectious diseases (cytomegalovirus -CMV). The most important differential diagnosis is mesenteric venous thrombosis, which does not show lymphocytic, necrotizing or granulomatous patterns of inflammation in the mesenteric veins. 5 Mesenteric venulitis has been reported in association with arterial vasculitis in SLE, 7 but in our case, no arteritis was demonstrated at histology, though splenic artery thrombosis and early arteriosclerotic changes were observed.
Coronary artery disease in SLE can result from accelerated atherosclerosis, arteritis, abnormal coronary flow reserve, spasm and thrombosis. Our patient had normal coronaries at coronarography. However, we cannot exclude that coronary thrombosis developed on coronaries possibly affected by the early, otherwise undetectable, intimal lesions as we observed histologically in splenic arteries. Alternatively, coronary thrombosis could have been due to a pro-coagulable state associated with seropositive or seronegative anti-phospholipid syndrome (APS), paradoxical embolism from LibmanSacks endocarditis or intra-cardiac shunt, drugs, infection, vasculitis or platelet hyperactivity. In our case Libman-Sacks endocarditis and intra-cardiac shunt were ruled out by appropriate tests. We cannot exclude that cardiolipin IgG documented at the time of the events could have played a role, though the low titre and transient presence render the involvement uncertain 8 . No overt infectious disease was observed in our case, although prophylactic rifampicin was introduced for latent tuberculosis, which has been described in rare cases to favour a pro-coagulable state. 9 GC are known to induce venous thrombosis 10 in association with endothelial lesions (not observed in our patient). Thus, the possibility exists that in our patient the inflammation linked with the SLE flare could have resulted in platelet hyperactivity, release of tissue factor and reduced the fibrinolytic activity through up-regulation of the production of plasminogen activator inhibitor.
11
In our patient, MIVOD developed in the month following a SLE flare under GC and antimalarial treatment, and two months before the occurrence of a myocardial infarction, with otherwise normal coronary arteries, which resembles a recently reported association between mesenteric vasculitis and myocardial infarction with normal coronary. 12 Thus, it is possible that splanchnic involvement may predispose to heart attack in SLE and foster increased attention to control otherwise subtle abnormalities. More generally, this case stresses the importance of better understanding and preventing vascular complications in SLE.
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